Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer

Breast Cancer Research

Volumn 4, Issue 3, 2002, Pages

  Sotiriou, Christos ^a,b   Powles, Trevor J ^c   Dowsett, Mitch ^c   Jazaeri, Amir A ^a   Feldman, Andrew L ^a   Assersohn, Laura ^c   Gadisetti, Chandramouli ^a   Libutti, Steven K ^a   Liu, Edison T ^a,d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JULES BORDET INSTITUTE   (Belgium)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

Breast cancer; CDNA microarray; Chemotherapy; Fine needle aspiration; Gene expression

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; CYCLOPHOSPHAMIDE; DOXORUBICIN; RNA;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER SURGERY; CLINICAL ARTICLE; DNA MICROARRAY; FEASIBILITY STUDY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYBRIDIZATION; MIDDLE AGED; PHARMACODYNAMICS; REPRODUCIBILITY; VALIDATION PROCESS; BREAST NEOPLASMS; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; NEEDLE BIOPSY; PATHOLOGY; PREDICTIVE VALUE; STANDARDS; TREATMENT OUTCOME; VALIDATION STUDY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 13844311931     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr433     Document Type: Article

References (22)

1. Early Breast Cancer Trialists' Collaborative Group: Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet. 1998, 352: 930-942. 10.1016/S0140-6736(98)03301-7.
2. Chang J, Powles TJ, Allred DC, Ashley SE, Clark GM, Makris A, Assersohn L, Gregory RK, Osborne CK, Dowsett M: Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer. J Clin Oncol. 1999, 17: 3058-3063.
3. Ellis PA, Smith IE, McCarthy K, Detre S, Salter J, Dowsett M: Pre-operative chemotherapy induces apoptosis in early breast cancer. Lancet. 1997, 349: 849-
4. Chang J, Ormerod M, Powles TJ, Allred DC, Ashley SE, Dowsett M: Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma. Cancer. 2000, 89: 2145-2152. 10.1002/1097-0142(20001201)89:11<2145::AID-CNCR1>3.0.CO;2-S.
5. Gruvberger S, Ringner M, Chen Y, Panavally S, Saal LH, Borg A, Ferno M, Peterson C, Meltzer PS: Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 2001, 61: 5979-5984.
6. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001, 98: 10869-10874. 10.1073/pnas.191367098.
7. Sotiriou C, Chand K, Petersen D, Jazaeri A, Liu ET: Core biopsies can be used to distinguish differences in expression profiling by cDNA microarrays. J Mol Diagn. 2002, 4: 30-36.
8. Eberwine J, Yeh H, Miyashiro K, Cao Y, Nair S, Finnell R, Zettel M, Coleman P: Analysis of gene expression in single live neurons. Proc Natl Acad Sci USA. 1992, 89: 3010-3014.
9. Wang E, Miller LD, Ohnmacht GA, Liu ET, Marincola FM: High-fidelity mRNA amplification for gene profiling. Nat Biotechnol. 2000, 18: 457-459. 10.1038/74546.
10. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998, 95: 14863-14868. 10.1073/pnas.95.25.14863.
11. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloom-field CD, Lander ES: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999, 286: 531-537. 10.1016/S0378-4371(00)00404-0.
12. He Q, Liang CH, Lippard SJ: Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin. Proc Natl Acad Sci USA. 2000, 97: 5768-5772. 10.1073/pnas.100108697.
13. Arioka H, Nishio K, Ishida T, Fukumoto H, Fukuoka K, Nomoto T, Kurokawa H, Yokote H, Abe S, Saijo N: Enhancement of cisplatin sensitivity in high mobility group 2 cDNA-transfected human lung cancer cells. Jpn J Cancer Res. 1999, 90: 108-115.
14. Desagher S, Martinou JC: Mitochondria as the central control point of apoptosis. Trends Cell Biol. 2000, 10: 369-377. 10.1016/S0962-8924(00)01803-1.
15. Muller I, Niethammer D, Bruchelt G: Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review). Int J Mol Med. 1998, 1: 491-494.
16. Denis-Gay M, Petit JM, Mazat JP, Ratinaud MH: Modifications of oxido-reductase activities in adriamycin-resistant leukaemia K562 cells. Biochem Pharmacol. 1998, 56: 451-457. 10.1016/S0006-2952(98)00084-7.
17. Naot D, Sionov RV, Ish-Shalom D: CD44: structure, function, and association with the malignant process. Adv Cancer Res. 1997, 71: 241-319.
18. Costa S, Terzano P, Bovicelli A, Martoni A, Angelelli B, Santini D, Ceccarelli C, Lipponen P, Erzen M, Syrjanen S, Syrjanen K: CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma. Gynecol Oncol. 2001, 80: 67-73. 10.1006/gyno.2000.6016.
19. Foskett SM, Ghose R, Tang DN, Lewis DE, Rice AP: Antiapoptotic function of CDK9 (TAK/P-TEFb) in U937 promonocytic cells. J Virol. 2001, 75: 1220-1228. 10.1128/JVI.75.3.1220-1228.2001.
20. Luparello C, Avanzato G, Carella C, Pucci-Minafra I: Tissue inhibitor of metalloprotease (TIMP)-1 and proliferative behaviour of clonal breast cancer cells. Breast Cancer Res Treat. 1999, 54: 235-244. 10.1023/A:1006121129382.
21. Schroder JK, Seidelmann M, Kirch HC, Seeber S, Schutte J: Assessment of resistance induction to cytosine arabinoside following transfer and overexpression of the deoxycytidylate deaminase gene in vitro. Leukoc Res. 1998, 22: 619-624. 10.1016/S0145-2126(98)00048-4.
22. Tukey JW: Tightening the clinical trial. Control Clin Trials. 1993, 14: 266-285. 10.1016/0197-2456(93)90225-3.